Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Acquires $4,927,425.06 in Stock

Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner bought 358,619 shares of the company’s stock in a transaction on Wednesday, November 13th. The stock was purchased at an average cost of $13.74 per share, with a total value of $4,927,425.06. Following the completion of the transaction, the insider now owns 5,810,700 shares in the company, valued at $79,839,018. This represents a 6.58 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Joshua Kushner also recently made the following trade(s):

• On Monday, November 11th, Joshua Kushner acquired 276,040 shares of Oscar Health stock. The stock was bought at an average price of $13.58 per share, with a total value of $3,748,623.20.

Oscar Health Price Performance

OSCR stock opened at $14.85 on Friday. The business has a 50 day moving average price of $18.20 and a 200 day moving average price of $18.26. The stock has a market cap of $3.59 billion, a price-to-earnings ratio of -247.50 and a beta of 1.67. Oscar Health, Inc. has a fifty-two week low of $6.93 and a fifty-two week high of $23.79. The company has a quick ratio of 0.91, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The business had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.29) EPS. Equities research analysts anticipate that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Oscar Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Versor Investments LP purchased a new stake in Oscar Health in the third quarter valued at approximately $787,000. Assenagon Asset Management S.A. lifted its stake in Oscar Health by 32.9% in the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after buying an additional 507,009 shares during the last quarter. FCG Investment Co purchased a new stake in Oscar Health in the third quarter valued at approximately $986,000. Jupiter Asset Management Ltd. purchased a new stake in Oscar Health in the first quarter valued at approximately $653,000. Finally, Toth Financial Advisory Corp lifted its stake in Oscar Health by 73,185.7% in the third quarter. Toth Financial Advisory Corp now owns 51,300 shares of the company’s stock valued at $1,088,000 after buying an additional 51,230 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on OSCR shares. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective for the company. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.93.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.